Baijin Life Science (HKG:1466) booked HK$1.5 million in attributable loss for the year ended March 31, narrowing from a loss of HK$9.5 million a year earlier, according to a Hong Kong bourse filing Friday.

Shares of the jewelry maker jumped over 4% in afternoon trade Monday.

Basic loss per share stood at HK$0.0005 compared to HK$0.0115 a year prior.

The company generated HK$135.6 million in revenue for the year, up from HK$53.7 million in the earlier fiscal year.